Velocity 2: An Anthrax Vaccine and Antibiotics Clinical Study
Clinical trial NCT04067011 · COMPLETED
Trial details
- NCT number
- NCT04067011
- Sponsor
- Emergent BioSolutions
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-12
- Primary completion
- 2020-03-05
- Enrollment
- 210
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.